Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that causes high blood pressure in the small arteries of the lungs. It is a serious condition that can impair blood flow ...

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.

The PAH Initiative is hosting a video event in May to provide information about exercise benefits for PAH patients.

is poor compared with other PAH types. A poor prognosis in scleroderma-related PAH (SSc-PAH) may be related to the multisystemic nature of the disease and, particularly, involvement of the heart.